{"id":"W2314438212","doi":"10.1097/00054725-200912002-00038","title":"Efficacy of certolizumab pegol is not affected by baseline anti-infliximab antibody status in patients with Crohnʼs disease with secondary infliximab failure","year":2009,"lang":"en","type":"article","venue":"Inflammatory Bowel Diseases","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Certolizumab pegol; Medicine; Infliximab; Internal medicine; Adalimumab; Maintenance therapy; Randomized controlled trial; Crohn's disease; Gastroenterology; Surgery; Disease; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001720712,0.0004199555,0.001564994,0.00028853,0.0003005602,0.0006890098,0.0002376015,0.0006117882,0.001056582],"category_scores_gemma":[0.002424365,0.0002663575,0.0009562265,0.0002997295,0.0004552972,0.0005555064,0.0003068767,0.0007003069,0.0002612705],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003180778,"about_ca_system_score_gemma":0.0003263732,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003513934,"about_ca_topic_score_gemma":0.0006830745,"domain_scores_codex":[0.9992765,0.0003795993,0.00006059483,0.00009300467,0.00007328151,0.0001170661],"domain_scores_gemma":[0.9979158,0.0006799514,0.0006668852,0.0001192325,0.00010247,0.0005156342],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.355372,0.003990786,0.5841405,0.0003254012,0.0009930518,0.0007698937,0.0002286845,0.0005441903,0.01368136,0.00005488967,0.0005964016,0.03930285],"study_design_scores_gemma":[0.03518952,0.1117849,0.8453619,0.00006270661,0.0006494861,0.001536488,0.0001231024,0.001280162,0.002367886,0.00009981012,0.001498711,0.00004506739],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9989156,0.0006209974,0.00004087126,0.00004058443,0.00001220334,0.00002362156,0.00007572738,0.000004073357,0.0002664552],"genre_scores_gemma":[0.9994955,0.00008320458,0.00005737123,0.00006076786,0.00002261296,0.00001583774,0.0001733149,0.000001802031,0.00008958393],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001720712,"threshold_uncertainty_score":0.00910008,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.002776589281517498,"score_gpt":0.2145625611673537,"score_spread":0.2117859718858362,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}